Covid Immunisation
- All
- News
- Videos
-
Mobile 3D Printer to Produce Thumbnail-Sized mRNA Covid Vaccine Patches Developed by Scientists: Details
A mobile 3D printer to produce thumbnail-sized patches capable of delivering mRNA Covid vaccines has been developed by scientists. The device is likely years away from being available and many hurdles remain, but the tabletop device could help immunise people in remote regions. A 3D printer can create two-centimetre-wide vaccine patches with hundre...
-
Jharkhand Seeks 50,000 Covid Vaccine Doses From Centre As Cases Rise
Amid rising cases of coronavirus, Jharkhand Health Minister Banna Gupta urged the Centre to provide at least 50,000 COVID-19 vaccine doses to continue with the immunisation drive in the state.
-
Thailand Reverses Covid Vaccination Entry Rule For Visitors
Thailand has rescinded an entry policy announced at the weekend requiring visitors to show proof of a COVID-19 vaccination, its health minister said on Monday, citing sufficient immunisation levels in China and globally.
-
Can't Be Liable To Compensate For Deaths Due To Covid Vaccines: Centre To Supreme Court
The government cannot be held liable to compensate for the deaths due to an adverse event following immunisation (AEFI) post administration of Covid-19 vaccines, the Centre has told the Supreme Court.
-
Routine Immunisations In India Suffered Due To Covid: Union Health Minister
Union Health Minister Mansukh Mandaviya on Thursday said routine immunisation was affected due to the coronavirus pandemic and the earlier vaccination programme has to be brought back on track.
-
Compensate Families Of Those Dead Due To Covid Vaccine Side Effects: Court
The Kerala High Court has directed the National Disaster Management Authority (NDMA) to "expeditiously" frame a policy for identifying those who died due to after effects of COVID-19 immunisation and compensating their dependents.
-
Gap Between 2nd Covid Jab, Booster Reduced On Immunisation Group Advice: Centre
Based on the recommendations made by the National Technical Advisory Group on Immunisation (NTAGI), the interval between the second and the precaution dose of Covid vaccines was revised from nine months to six months for all beneficiaries.
-
Haryana Man Thrashes Heath Workers For Vaccinating Daughter, Arrested
A man was arrested in Haryana on Wednesday for allegedly abusing and beating health workers for administering a Covid vaccine dose to his daughter who was brought to the immunisation centre by her mother, police said.
-
Death Rates Low Despite Rise In Covid Cases Due To Vaccination: Centre
The COVID-19 case trajectory in some states is witnessing an upward trend since May but hospitalisation and death rates are low which can be attributed to immunisation efforts across India, the Lok Sabha was told Friday.
-
COVID-19 Working Group To Review Data For Covovax Vaccine On Friday: Report
The COVID-19 working group of the National Technical Advisory on Immunisation (NTAGI) will be reviewing the data of Serum Institute of India's vaccine - Covovax for use for children and adults, on April 1, sources said today.
-
Covishield Dose Gap Reduced To 8-16 Weeks From 12-16
India's apex body on immunisation NTAGI has recommended administering the second dose of COVID-19 vaccine Covishield between eight and 16 weeks after the first dose.
-
Anti-Covid Pill Shouldn't Be Given To Younger Population: Covid Panel Head
Molnupiravir used in treatment of Covid should not be administered to younger population as it adversely affects their reproductive system, said Dr NK Arora, Chairman of Covid Working Group of National Technical Advisory Group on Immunisation (NTAGI)
-
Covaxin Shelf-Life Extension Not A Problem: Covid Task Force Chief
It is absolutely safe, underlined the head of the India's vaccine task force chief on the vexing question of extending the shelf life of Covid vaccine, Covaxin, being given to teenagers (15-18) under the national Covid immunisation programme.
-
"Reports That Expired Covid Shots Being Given False, Misleading": Centre
Reports claiming that expired vaccines in the 15 to 18 age group are being given under national COVID-19 vaccination programme are false and misleading, the government clarified today, adding that the reports used "incomplete information".
-
Covaxin Showed Good Response In Children During Trials: Covid Panel Chief
Covaxin has shown that it has a very good immune response in children in trials, Chairman of India's COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI) Dr NK Arora said on Sunday.
-
Mobile 3D Printer to Produce Thumbnail-Sized mRNA Covid Vaccine Patches Developed by Scientists: Details
A mobile 3D printer to produce thumbnail-sized patches capable of delivering mRNA Covid vaccines has been developed by scientists. The device is likely years away from being available and many hurdles remain, but the tabletop device could help immunise people in remote regions. A 3D printer can create two-centimetre-wide vaccine patches with hundre...
-
Jharkhand Seeks 50,000 Covid Vaccine Doses From Centre As Cases Rise
Amid rising cases of coronavirus, Jharkhand Health Minister Banna Gupta urged the Centre to provide at least 50,000 COVID-19 vaccine doses to continue with the immunisation drive in the state.
-
Thailand Reverses Covid Vaccination Entry Rule For Visitors
Thailand has rescinded an entry policy announced at the weekend requiring visitors to show proof of a COVID-19 vaccination, its health minister said on Monday, citing sufficient immunisation levels in China and globally.
-
Can't Be Liable To Compensate For Deaths Due To Covid Vaccines: Centre To Supreme Court
The government cannot be held liable to compensate for the deaths due to an adverse event following immunisation (AEFI) post administration of Covid-19 vaccines, the Centre has told the Supreme Court.
-
Routine Immunisations In India Suffered Due To Covid: Union Health Minister
Union Health Minister Mansukh Mandaviya on Thursday said routine immunisation was affected due to the coronavirus pandemic and the earlier vaccination programme has to be brought back on track.
-
Compensate Families Of Those Dead Due To Covid Vaccine Side Effects: Court
The Kerala High Court has directed the National Disaster Management Authority (NDMA) to "expeditiously" frame a policy for identifying those who died due to after effects of COVID-19 immunisation and compensating their dependents.
-
Gap Between 2nd Covid Jab, Booster Reduced On Immunisation Group Advice: Centre
Based on the recommendations made by the National Technical Advisory Group on Immunisation (NTAGI), the interval between the second and the precaution dose of Covid vaccines was revised from nine months to six months for all beneficiaries.
-
Haryana Man Thrashes Heath Workers For Vaccinating Daughter, Arrested
A man was arrested in Haryana on Wednesday for allegedly abusing and beating health workers for administering a Covid vaccine dose to his daughter who was brought to the immunisation centre by her mother, police said.
-
Death Rates Low Despite Rise In Covid Cases Due To Vaccination: Centre
The COVID-19 case trajectory in some states is witnessing an upward trend since May but hospitalisation and death rates are low which can be attributed to immunisation efforts across India, the Lok Sabha was told Friday.
-
COVID-19 Working Group To Review Data For Covovax Vaccine On Friday: Report
The COVID-19 working group of the National Technical Advisory on Immunisation (NTAGI) will be reviewing the data of Serum Institute of India's vaccine - Covovax for use for children and adults, on April 1, sources said today.
-
Covishield Dose Gap Reduced To 8-16 Weeks From 12-16
India's apex body on immunisation NTAGI has recommended administering the second dose of COVID-19 vaccine Covishield between eight and 16 weeks after the first dose.
-
Anti-Covid Pill Shouldn't Be Given To Younger Population: Covid Panel Head
Molnupiravir used in treatment of Covid should not be administered to younger population as it adversely affects their reproductive system, said Dr NK Arora, Chairman of Covid Working Group of National Technical Advisory Group on Immunisation (NTAGI)
-
Covaxin Shelf-Life Extension Not A Problem: Covid Task Force Chief
It is absolutely safe, underlined the head of the India's vaccine task force chief on the vexing question of extending the shelf life of Covid vaccine, Covaxin, being given to teenagers (15-18) under the national Covid immunisation programme.
-
"Reports That Expired Covid Shots Being Given False, Misleading": Centre
Reports claiming that expired vaccines in the 15 to 18 age group are being given under national COVID-19 vaccination programme are false and misleading, the government clarified today, adding that the reports used "incomplete information".
-
Covaxin Showed Good Response In Children During Trials: Covid Panel Chief
Covaxin has shown that it has a very good immune response in children in trials, Chairman of India's COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI) Dr NK Arora said on Sunday.
